Performance of KURN Kuros Biosciences AG | 796.2% in 12m
Compare KURN with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?
Compare Kuros Biosciences AG with its related Sector/Index XLV
Performance Duell KURN vs XLV
| TimeFrame | KURN | XLV |
|---|---|---|
| 1 Week | 21.4% | -0.25% |
| 1 Month | 18.6% | -1.71% |
| 3 Months | 87.0% | 1.61% |
| 6 Months | 218.3% | 10.92% |
| 12 Months | 796.2% | 20.88% |
| YTD | 567.6% | 11.05% |
| Rel. Perf. 1m | 1.58 | |
| Rel. Perf. 3m | 8.50 | |
| Rel. Perf. 6m | 10.45 | |
| Rel. Perf. 12m | 20.02 | |
| Spearman 1m | 0.36 | -0.373 |
| Spearman 3m | 0.90 | 0.464 |
Is Kuros Biosciences AG a good stock to buy?
Probably not. Based on ValueRay Fundamental Analyses, Kuros Biosciences AG (SW:KURN) is currently (October 2024)
not a good stock to buy. It has a ValueRay Fundamental Rating of -40.25 and therefor a somewhat negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of KURN as of October 2024 is 56.14. This means that KURN is currently undervalued and has a potential upside of +131.98% (Margin of Safety).
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of KURN as of October 2024 is 56.14. This means that KURN is currently undervalued and has a potential upside of +131.98% (Margin of Safety).
Is KURN a buy, sell or hold?
Kuros Biosciences AG has no consensus analysts rating. ValueRay therefore judges the recommendation based on the last 12 Month Returns of 796.15%.
In compare to Health Care Sector SPDR Fund, KURN made 775.27% more over the last 12 months. Due to the outperformance, it is recommend to buy KURN.
In compare to Health Care Sector SPDR Fund, KURN made 775.27% more over the last 12 months. Due to the outperformance, it is recommend to buy KURN.
Values above 0%: KURN is performing better - Values below 0%: KURN is underperforming
Compare KURN with Broad Market Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 20.27% | 14.90% | 201.23% | 756.02% |
| US NASDAQ 100 | QQQ | 21.62% | 14.74% | 202.60% | 756.66% |
| US Dow Jones Industrial 30 | DIA | 19.52% | 14.69% | 202.76% | 763.30% |
| German DAX 40 | DBXD | 20.37% | 14.30% | 209.27% | 766.26% |
| UK FTSE 100 | ISFU | 20.86% | 19.36% | 204.81% | 771.95% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 29.78% | 1.71% | 209.97% | 784.81% |
| Hongkong Hang Seng | HSI | 26.28% | 9.55% | 194.46% | 785.08% |
| Japan Nikkei 225 | EXX7 | 21.80% | 14.49% | 215.09% | 773.18% |
| India NIFTY 50 | INDA | 22.68% | 21.44% | 207.77% | 768.05% |
| Brasil Bovespa | EWZ | 21.77% | 24.57% | 221.10% | 794.72% |
KURN Kuros Biosciences AG vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 20.51% | 15.16% | 204.41% | 758.53% |
| Consumer Discretionary | XLY | 20.69% | 15.53% | 202.50% | 764.06% |
| Consumer Staples | XLP | 20.28% | 19.80% | 205.04% | 770.74% |
| Energy | XLE | 23.08% | 14.48% | 220.44% | 792.27% |
| Financial | XLF | 17.01% | 13.23% | 197.44% | 745.87% |
| Health Care | XLV | 21.60% | 20.35% | 207.39% | 775.27% |
| Industrial | XLI | 19.25% | 13.08% | 202.89% | 753.31% |
| Materials | XLB | 19.28% | 14.43% | 208.04% | 764.44% |
| Real Estate | XLRE | 18.00% | 19.21% | 191.82% | 755.73% |
| Technology | XLK | 21.49% | 13.47% | 202.19% | 754.76% |
| Utilities | XLU | 17.63% | 14.91% | 189.26% | 751.12% |
| Aerospace & Defense | XAR | 17.59% | 11.64% | 194.70% | 753.30% |
| Biotech | XBI | 18.15% | 20.26% | 200.84% | 747.53% |
| Homebuilder | XHB | 17.99% | 16.48% | 194.60% | 719.57% |
| Retail | XRT | 16.89% | 15.89% | 206.87% | 762.34% |
Does Kuros Biosciences AG outperform its market, is KURN a Sector Leader?
Yes, over the last 12 months Kuros Biosciences AG (KURN) made 796.15%, while its related Sector, the Health Care Sector SPDR Fund (XLV) made 20.88%.
Over the last 3 months KURN made 87.00%, while XLV made 1.61%.
Yes, over the last 12 months Kuros Biosciences AG (KURN) made 796.15%, while its related Sector, the Health Care Sector SPDR Fund (XLV) made 20.88%.
Over the last 3 months KURN made 87.00%, while XLV made 1.61%.
| Period | KURN | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 18.64% | -1.71% | 3.74% |
| 3 Months | 87.00% | 1.61% | 4.88% |
| 12 Months | 796.15% | 20.88% | 40.13% |